This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
27-30 April 2026
Vienna Congress & Convention CenterVienna, Austria
Book Now
Menu
Book Now
keyboard_arrow_right

Main Conference Day 3 (30th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)

keyboard_arrow_leftSearch & Filter
search
Main Conference Day 3 (30th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)
search
Showing 1 of 1 Streams
08:30 - 08:55
Morning Coffee
Showing 5 of 5 Streams
08:55 - 09:00
Chairperson's Opening Remarks
  • Eden Turner - Senior Conference Producer, Informa Connect
09:00 - 09:30
Epigenetic Informed Digital Twins for Predictive Modeling of Cellular Behavior in Biopharmaceutical Systems
  • Karlheinz Landauer - Managing Director, QBDC GmbH
09:30 - 10:00
What’s next for biopharmaceutical production expression vectors?
  • Adam Brown, Ph.D. - Professor of Biopharmaceutical Engineering, University of Sheffield
10:00 - 10:30
Accelerate your Cell Line Journey – How high-performance Cell Line Development shortens time from DNA to IND
  • Britta Reichenbächer - Senior Process Manager Process Science, Rentschler Biopharma
08:55 - 09:00
Chairperson's Opening Remarks
  • Melanie Dannemeyer - Associate Director, Biopharma Drug Substance, AstraZeneca
09:00 - 09:30
GMP-compliant Upstream Process Development for The Production of Therapeutic Exosome-rich Secretomes
  • Mario Gimona - Head of R&D 'Nanovesicular Therapeutics', Ludwig Boltzmann Institute of Nanovesicular Precision Medicine & Paracelsus Medical University, Austria
09:30 - 10:00
Going Viral: Scaling Robust AAV Production in Suspension
  • Giovanni Ganendra - Upstream Process Science Senior Scientist, UCB Pharma
10:00 - 10:30
Purity that Powers Performance: The foundation of batch-to-batch consistency in bioprocessing highlighting Super Refined™ Poloxamer 188, BioXPro™ Amino Acids and Virodex™
  • Geoff Platt - Technology Specialist, Croda Europe Ltd.
09:25 - 09:30
Chairperson's Opening Remarks
  • Harry Starkey - Research Manager, Informa Connect
09:30 - 10:00
Digital Twins for Better Continuous Downstream Processing
  • Dong-Qiang Lin - Professor, Zhejiang University
10:00 - 10:30
Cleaner Feeds, Smarter Selectivity: Coordinating AEX Clarification with Advanced Chromatographic Polishing for Antibody Impurity Control
  • Jack Cordrey - Senior Bioprocessing Specialist, Thermo Fisher Scientific
  • Buzz Lobbezoo - Senior Field Applications Scientist, Thermo Fisher Scientific
08:55 - 09:00
Chairperson's Opening Remarks
  • Stefano Menegatti - Professor, Chemical and Biomolecular Engineering, NC State University, North Carolina State University
09:00 - 09:30
Beyond mRNA: Developing an Integrated Manufacturing for ADDomer-Based Vaccines
  • Salomé Mateus Forte Neto - PhD Student, iBET
09:30 - 10:00
Harnessing Nature's Nanoparticle: Process Development of Exosomes for Drug Delivery
  • Lior Shaltiel - CEO, NurExone Biologic
10:00 - 10:30
Please Move to Another Track
08:55 - 09:00
Chairperson's Opening Remarks
  • Christian Witz - CEO, SimVantage GmbH
09:00 - 09:30
[BioPhorum Case Study] Structured Data for Regulatory CMC – Enabling Agile, Harmonized Submissions Through Digital Transformation
  • Chris Le Page - Associate Director CMC Regulatory Affairs, UCB
09:30 - 10:00
AI Governance in Biopharma
  • Maria Boulieri - Lead Privacy Counsel, Europe, Chiesi Group
10:00 - 10:30
A Model-Based Blueprint for a Scalable and Robust Protein Purification Process
  • David Pfister - Head of Research & Development, Ypso-Facto
  • Cornelia Walther - Principal Scientist Downstream Development | Development Operations Vienna, Boehringer Ingelheim RCV GmbH & Co KG
Showing 1 of 1 Streams
10:30 - 11:15
Morning Networking Break in the Exhibit Hall
Showing 5 of 5 Streams
11:15 - 11:45
Proteomics-Driven ER Stress Insights for Biomanufacturing Efficiency
  • Paula Meleady - Associate Professor, School of Biotechnology, Dublin City University
11:45 - 12:15
Uncovering Structural and Phenotypic Drivers of Productivity in CHO Cells
  • Zeynep Betts, PhD - Postdoctoral Research Associate, University of Manchester
12:15 - 12:45
AbZelectPRO™ – Powering the Fast Track from DNA to Clinic
  • Tanya Knight - Senior Manager of Cell Line Development, Abzena
11:15 - 11:45
Raw Material Variability Impact on Cell Culture and CQAs
  • Sinead Dullaghan - Sr. Principal Scientist TSMS, Eli Lilly
11:45 - 12:15
Application of an AMBR Bioreactor Model for Characterizing DO Excursions in High Throughput Cell Culture
  • Christopher Sevinsky, Ph.D. - Director, Process and Cell Bank Characterization - Global Process Sciences, Regeneron
  • Christina Calabrese, Ph.D. - Manager, Regulatory Affairs, Regeneron
12:15 - 12:45
Closing the PAT Gap: Innovative Calibration-Light In-Situ Mid-IR Glucose Sensor for Automated Perfusion and Fed-batch Control
  • Giovanni Campolongo - Senior Market Segment Manager Process Analytics, Hamilton Bonaduz AG
11:15 - 11:45
The Hidden Factory: Strategies for Automating Buffer Preparation and Management
  • Tiffany D Rau, PhD - Principal Consultant BioPharma Technical Consulting and Rau Consulting, Adjunct Professor Biochemistry and Cell Biology, University College Cork, Ireland
11:45 - 12:15
The Future is Green: The Shift Towards Bio-Based Solutions in Bioseparation
  • Ana Cecilia Afonso Roque - Professor in Bioengineering, NOVA University of Lisbon
12:15 - 12:45
"Case Studies with the NEW Planova™ Virus Removal Filters: “S20N – a filter for challenging solutions” and “FG1 – a rapid flux filter"
  • Haiko Fischer - Senior Product Manager, Asahi Kasei Bioprocess Europe
11:15 - 11:45
Point-of-Care in ARI CAR-T program: the Spanish public model for an accessible advanced therapies
  • Manel Juan - Head of the Immunology Department, Hospital Clínic de Barcelona, Spain
11:45 - 12:15
PANEL DISCUSSION: Blueprint for Tomorrow's ATMP Factory - Centralised, Decentralised, and Hybrid Models
  • Tiffany D Rau, PhD - Principal Consultant BioPharma Technical Consulting and Rau Consulting, Adjunct Professor Biochemistry and Cell Biology, University College Cork, Ireland
  • Manel Juan - Head of the Immunology Department, Hospital Clínic de Barcelona, Spain
  • Moritz von Stosch - Co Founding Partner, HINA Bioventures
12:15 - 12:45
Please Move to Another Track
11:15 - 11:55
Implementing Process Analytical Technology (PAT) to Enable Faster, Data-Driven Decisions
  • Maxime Bergman - Senior Scientist Process II - Global Process Development, TDS, Drug Product Development & Delivery, Johnson & Johnson Innovative Medicine
  • Marius Müller - Scientific Senior Manager - TDS Biologics AD, Johnson & Johnson Innovative Medicine
  • Craig Walsh - Experienced Scientist MST - Clinical Manufacturing & Technology, Johnson & Johnson Innovative Medicine
11:55 - 12:15
Fireside Chat: What Can Biopharma Learn from the Digital Journeys of Other Regulated Industries?
  • Christian Witz - CEO, SimVantage GmbH
  • Matthew Todd - CTO & Founder, Intellure Ltd
12:15 - 12:45
Please Move to Another Track
Lunch, Networking & Exhibit Hall Content
Showing 2 of 2 Streams
12:45 - 13:55
Lunch in the Exhibit Hall
12:50 - 13:50ROUNDTABLE
Implementation of Collaboration – The Future Role Model for Resilient Biologics Supplies
  • Uwe Buecheler - Chairman of the Board, Biopharma Cluster South Germany
  • Janosch Klebensberger - Manager, Biopharma Cluster South Germany
Showing 4 of 4 Streams
13:55 - 14:55
PLENARY PANEL DISCUSSION: The 15 g/L Challenge: Charting the Path to the Next Tipping Point
  • Lekan Daramola - Consultant, LD BioConsulting Limited
  • Patrick Harnedy - Senior Principal Engineer, Eli Lilly
  • Gearóid Duane - Senior Principal Scientist, Bristol Myers Squibb, Cruiserath Biologics
  • Eugenio Macchiarulo, Ph.D. - Director Research & Development, Lonza
  • Christian Munch - CEO, Enduro Genetics
13:55 - 14:55
[Plenary hosted in Cell Line Development & Engineering] PLENARY PANEL DISCUSSION: The 15 g/L Challenge: Charting the Path to the Next Tipping Point
  • Lekan Daramola - Consultant, LD BioConsulting Limited
  • Patrick Harnedy - Senior Principal Engineer, Eli Lilly
  • Gearóid Duane - Senior Principal Scientist, Bristol Myers Squibb, Cruiserath Biologics
  • Eugenio Macchiarulo, Ph.D. - Director Research & Development, Lonza
  • Christian Munch - CEO, Enduro Genetics
13:55 - 14:25
CASE STUDY: From Trial-and-Error to Predictive Bioprocessing: Accelerating ATMP Development
  • Matthias Müllner - CEO, bespark*bio
  • Mark Duerkop - Chief Executive Officer, Novasign, Austria
14:25 - 14:55
PANEL DISCUSSION: Data and Automation to Tackle the COGs Crisis?
  • Stefano Menegatti - Professor, Chemical and Biomolecular Engineering, NC State University, North Carolina State University
  • Andrew Harmon - Manager, Sia Partners
  • Dénes Zalai - Director Technology, Eleva Biologics
  • Isabella Deutsch - Applied Machine Learning Researcher, Danu Insights
13:55 - 14:25
[Plenary hosted in ATMP Development & Manufacturing] CASE STUDY: From Trial-and-Error to Predictive Bioprocessing: Accelerating ATMP Development
  • Matthias Müllner - CEO, bespark*bio
  • Mark Duerkop - Chief Executive Officer, Novasign, Austria
14:25 - 14:55
[Plenary hosted in ATMP Development & Manufacturing] PANEL DISCUSSION: Data and Automation to Tackle the COGs Crisis?
  • Stefano Menegatti - Professor, Chemical and Biomolecular Engineering, NC State University, North Carolina State University
  • Andrew Harmon - Manager, Sia Partners
  • Dénes Zalai - Director Technology, Eleva Biologics
  • Isabella Deutsch - Applied Machine Learning Researcher, Danu Insights
END OF BPI EUROPE 2026
Showing 1 of 1 Streams
14:55 - 15:00
End of Conference
Main Conference Day 2 (29th April 2026)
Filter
Streams
Choose Day